Kinsey, C., et al. A versatile reversed-phase liquid chromatography charged aerosol detection method for streamlined monitoring of QS-21 content and stability in liposomal adjuvant formulations. J Chromatogr B Analyt Technol Biomed Life Sci, 2026 Oct 1, 1282:125220. PMID: 42520362
This paper introduces a novel and highly effective liquid chromatography-charged aerosol detection (LC-CAD) method for monitoring the content and stability of QS-21, a potent saponin adjuvant, and its hydrolytic degradation product (QS-21 HP) in liposomal vaccine formulations.
This work addresses a critical challenge: the reliable quantification of QS-21 and its variants within complex liposomal matrices, which has previously been hampered by a “paucity of reliable assays”. The new aspect of this paper lies in its development of a simple, quality control (QC)-friendly LC-CAD method that leverages 2.7 μm fused-core phenyl hexyl particles and incorporates in silico method development optimization. This approach is significant because QS-21, a glycosylated triterpene saponin isolated from Quillaja Saponaria Molina bark, is widely used in licensed vaccines (e.g., shingles, malaria, RSV) and is under evaluation in numerous clinical trials. The background to this importance stems from the fact that QS-21 is susceptible to pH and temperature-dependent hydrolytic degradation in aqueous environments, forming QS-21 HP, which has distinct immune response profiles and can reduce adjuvant activity and increase reactogenicity and hemolysis.
The new LC-CAD method offers the following benefits: Versatility: Adaptable for both standard and UHPLC systems using 2.7 μm fused-core phenyl hexyl particles. QC-Ready: Simple, robust, and easily deployable in quality control environments. Accurate & Precise: High correlation between predicted and experimental results, with excellent linearity, precision, and accuracy. Enhanced Detection: Utilizes Charged Aerosol Detection (CAD) for sensitive, universal detection of analytes like QS-21, which lack strong UV chromophores. Streamlined Monitoring: Efficiently monitors QS-21 content and stability, including its degradants. Overcomes Past Limitations: Addresses the previous lack of reliable assays for QS-21 and its degradants in complex formulations. Supports Development: Critical for the clinical development and commercialization of new QS-21-containing vaccine formulations.
Precisely monitoring the intact QS-21 and its degradants is crucial for ensuring the safety and efficacy of vaccine products, making this robust and transferable LC-CAD method a valuable advancement for the development and commercialization of saponin-based adjuvant formulations.
Click here to access the full scientific paper.
[arrow_forms id=’3298′]

